A Topological and Spatial Analysis of FDA-Approved Drugs, Blood-Brain Barrier Permeants, Natural Products, and Metabolites.

Masand VH, Al-Hussain SA, Quadri MSA, Samad A, Zaki MEA

Open source

DOI
10.1002/cmdc.70462
Published
2026 Sep 14
Container
ChemMedChem
Publisher
Not recorded
Open access
yes

Credibility signals

limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1002/cmdc.70462,
  title = {A Topological and Spatial Analysis of FDA-Approved Drugs, Blood-Brain Barrier Permeants, Natural Products, and Metabolites.},
  author = {Masand VH and Al-Hussain SA and Quadri MSA and Samad A and Zaki MEA},
  year = {2026},
  journal = {ChemMedChem},
  doi = {10.1002/cmdc.70462},
  url = {https://doi.org/10.1002/cmdc.70462}
}

RIS

TY  - JOUR
TI  - A Topological and Spatial Analysis of FDA-Approved Drugs, Blood-Brain Barrier Permeants, Natural Products, and Metabolites.
AU  - Masand VH
AU  - Al-Hussain SA
AU  - Quadri MSA
AU  - Samad A
AU  - Zaki MEA
PY  - 2026
JO  - ChemMedChem
DO  - 10.1002/cmdc.70462
UR  - https://doi.org/10.1002/cmdc.70462
ER  - 

APA

VH, M., SA, A., MSA, Q., A, S., & MEA, Z. (2026). A Topological and Spatial Analysis of FDA-Approved Drugs, Blood-Brain Barrier Permeants, Natural Products, and Metabolites.. ChemMedChem. https://doi.org/10.1002/cmdc.70462

Source records